Investors
Zevra is a rare disease therapeutics company driven by science, data and patient need to create transformational therapies for diseases with limited or no treatment options.
Visit www.KeepZevraStrong.com for more on voting the WHITE card in support of Zevra’s plan for value creation at the upcoming 2023 Annual Meeting of Stockholders.